Studies show that plant-based diets can help lower prostate-specific antigen (PSA levels), improve serum testosterone and erectile dysfunction.
In a new National Institutes of Health (NIH) initiative, the University of Miami Miller School of Medicine was selected for a nationwide Liver Cirrhosis Network. Researchers in the network’s 10 academic medical centers will share patient data and launch clinical trials of a class of medications that could prevent progression of the disease, which causes irreversible scarring of the liver, and complications such as liver cancer.
Concerned about relatively low COVID-19 vaccination rates among U.S. Blacks and Latinos, Glenn Flores, M.D., chair of pediatrics at the University of Miami Miller School of Medicine, is helping to guide a faith-based initiative addressing one of the nation’s most pressing healthcare challenges.
The University of Miami’s Miller School of Medicine will be one of only three sites in the nation to test a potentially revolutionary opto-electrical cochlear implant, which could improve quality of life for millions with hearing loss.
A University of Miami Miller School of Medicine biochemistry researcher has found that a nanoparticle drug delivery system can reduce HIV/AIDS viral reservoirs in the brain that normally contribute to neurological problems.
Three years after the National Institutes of Health (NIH) launched its 10-year All of Us Research Program, a regional team led by University of Miami Miller School of Medicine faculty has achieved remarkable success in recruiting members of minority communities including Black and Latino participants.
In a newly published study, physician-scientists at the University of Miami Miller School of Medicine have shown that the flu vaccine may provide vital protection against COVID-19.
The University’s coronavirus sequencing effort uncovered that there are several variants present in its patient population, but Delta is chief among them and easily transmitted. And its presence is likely triggering a local surge in the infectious disease. University of Miami researchers and physicians are seeing firsthand how rapidly the Delta variant of COVID-19 is spreading through the local population.
The University of Miami Miller School of Medicine is helping to lead a National Institutes of Health (NIH) COVID-19 testing initiative to safely return children to in-person school.
Declining health and fitness are commonly known to accompany spinal cord injuries and disorders (SCI/D). During the past few decades, attention has also focused on including five critical health hazards: overweight/obesity, insulin resistance, hypertension, and lipid abnormalities.
A study shows for the first time that people with cirrhosis who receive mRNA COVID-19 vaccination gain important protection against more serious outcomes like hospitalization and death. At the same time, however, the vaccines offer less protection against SARS-CoV-2 infection and take longer to take effect in this population.
There is also the emerging understanding that overcoming systemic racism helps ensure that everyone has a chance to access advanced education and training. To help drive this change, the Department of Neurological Surgery at the University of Miami Miller School of Medicine has established the Black Lives Matter Fellowship to support Black students who want to conduct advanced work in neuroscience or neurosurgery.
To many, heart failure means a person is at the end of life, struggling for breath. But that is not reality for most heart failure patients. The Cardiovascular Division at the University of Miami Miller School of Medicine is addressing the needs of today’s heart failure patients by expanding the Heart Failure program to not only care for those with advanced heart failure but to also help patients with the disease live full lives, and to help those at risk for heart failure.
The Pfizer and Moderna mRNA COVID-19 vaccines is safe for male reproduction, according to a new study by University of Miami Miller School of Medicine researchers published in JAMA , the most widely circulated general medical journal in the world.
The $2.3 million, four-year Avenir Award will support his innovative research project, “Tele-Harm Reduction for Rapid Initiation of Antiretrovirals in People Who Inject Drugs: A Randomized Controlled Trial.”
Clinician researchers at the University of Miami Miller School of Medicine have shown that patients don’t necessarily need opioids for pain relief following robotic prostatectomies. In a study published in the Journal of Robotic Surgery, the team found that strategic use of local anesthetic and non-steroidal anti-inflammatory drugs (NSAIDs) plus acetaminophen can effectively control post-surgical pain without narcotics.
Poor sleep impacts the risk of long-term cognitive decline in Hispanic/Latino middle aged and older adults differently than it does in non-Hispanic adults, according to research led by University of Miami Miller School of Medicine neurology faculty and the largest long-term study of U.S. Hispanic/Latinos to date.
According to a new study caffeine withdrawal can be a severe problem for surgery patients, who can’t eat or drink anything for hours before their procedures. This can result in major side effects, complicate treatment and extend hospital stays.
University of Miami Miller School of Medicine researchers report the widespread blood vessel dysfunction, or endothelial dysfunction, that results from the COVID-19 infection could contribute to erectile dysfunction, or ED, according to a study published in the World Journal of Men’s Health .
From the impact of COVID-19 on parents, to speech differences between English- and Spanish-learners, and advanced ear surgery techniques, University of Miami Miller School of Medicine hearing professionals presented their latest studies at CI2021, the annual conference of the American Cochlear Implant (ACI) Alliance, from April 28 to May 1.
A new study led by a University of Miami Miller School of Medicine researcher underscores the importance of screening adolescents with hearing loss for depression and anxiety.
David Goldberg, M.D., M.S.C.E., associate professor of medicine in the Division of Digestive Health and Liver Diseases at the University of Miami Miller School of Medicine, is one of three principal investigators of a five-year, $7.8 million National Institutes of Health-funded study using donor kidneys infected with hepatitis C (HCV) in patients awaiting kidney transplants who do not have HCV.
Researchers with the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine and Vertex Pharmaceuticals Incorporated have initiated clinical trials for VX-880, a novel investigational cell therapy with the potential to restore normal glucose control in people suffering from type 1 diabetes with severe hypoglycemia and impaired hypoglycemic awareness. The University of Miami Health System was the first clinical site activated for this trial.
American Urological Association Awards 3 Grants to Miller School Researchers
Michael E. Hoffer, M.D., FACS, professor of otolaryngology and neurological surgery at the University of Miami Miller School of Medicine, is editor-in-chief of the newly launched gold open access journal Otology & Neurotology Open, the official open access scientific journal of the American Otological Society and American Neurotology Society.
In a study published in Nature Communications, researchers at Sylvester Comprehensive Cancer Center have shown that whole genome sequencing can help determine which patients with a multiple myeloma precursor condition, called MGUS or smoldering myeloma, progress to full-blown cancer
Research published in the AACR journal Cancer Discovery found that a protein named chemerin is present in higher quantities in the blood of obese individuals and plays an essential role in controlling fat metabolism in kidney cancer cells.
University of Miami Miller School of Medicine study, “Assessment of the Disparities Associated With a Crisis Standards of Care Resource Allocation Algorithm for Patients in Two U.S. Hospitals During the COVID-19 Pandemic,” published March 11 in JAMA Network Open, a journal of the American Medical Association.
A new study published online in the Annals of the American Thoracic Society reveals how socioeconomic factors partially explain the increased odds that Black and Hispanic Americans have of testing positive for SARS-CoV-2, the virus that causes COVID-19.
Please join us for a national conversation on the ethical considerations regarding COVID-19 vaccination programs on college campuses and at academic medical centers. Wednesday, March 17, 6:30-7:30pm ET.
A team of University of Miami researchers working to detect variants of the novel coronavirus has found that approximately 25 percent of COVID-19 positive patients in the past two weeks were stricken with the more contagious U.K. variant. In addition, they have found three samples of the Brazilian variant, which could be one of the first times that strain has been identified in South Florida.
In this study, among Caribbean-born individuals with breast and ovarian cancer, 1 in 7 had hereditary breast and ovarian cancer. The proportion of hereditary breast and ovarian cancer varied by island and each island had a distinctive set of variants.
The University of Miami Miller School of Medicine was awarded a new five-year, $2 million grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) for “Application of Mild Therapeutic Hypothermia for Hearing Conservation During Cochlear Implant Surgeries.” It follows a pilot grant from the CTSI, a small business innovation grant from the National Institutes of Health, and industry funding to Dr. Suhrud Rajguru, Ph.D., associate professor at the Miller School of Medicine in biomedical engineering and otolaryngology, and his laboratory.
University of Miami Miller School of Medicine researchers are recruiting health care workers to study whether a wearable device, a wristwatch, can capture real time data that can be used to alert wearers of subtle physiological changes that may indicate they have become infected with COVID-19.
An innovative mitral valve replacement procedure shows promise for high-risk patients in a new University of Miami Miller School of Medicine study led by Joseph Lamelas, M.D., chief and program director of cardiothoracic surgery.
Minimally invasive aortic valve replacement surgery is a safer procedure than indicated by current surgical risk scores, according to a study published in Innovations, the journal of the International Society for Minimally Invasive Cardiothoracic Surgery, led by Joseph Lamelas, M.D., chief and program director of cardiothoracic surgery at the University of Miami Health System.
Research by scientists at the University of Miami Miller School of Medicine has shown that sodium fluorescein, a sodium salt and organic fluorescent dye that makes vestibular schwannoma tumors glow neon green, may help surgeons improve the safety and outcomes of an otherwise complicated brain surgery.
The University of Miami Health System is one of five sites nationally and the only one in the Southeast U.S. chosen to participate in a National Institute of Allergy and Infectious Diseases (NIAID) study looking at people who have had COVID-19 or have had a COVID-19 vaccine to examine the durability and robustness of participants’ antibody and T-cell responses to the virus.
Sylvester Comprehensive Cancer Center researchers are looking at ways to combine imaging and biomarkers to predict prostate cancer progression more accurately.
Researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are collaborating with faculty at the University of Pennsylvania to develop a risk score that more comprehensively prioritizes liver cancer patients for transplantation.
University of Miami Miller School of Medicine researchers led a unique and groundbreaking randomized controlled trial showing umbilical cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken time to recovery for the severest COVID-19 patients, according to results published in STEM CELLS Translational Medicine in January 2021.
With strong support from community partners, University of Miami Health System pediatric professionals have tested more than 10,000 Miami-Dade children for COVID-19, providing a vital service to families without convenient access to care.
University of Miami Miller School of Medicine researchers have begun recruiting for a study looking at the impact of the COVID-19 vaccine on male fertility. The Miller School is the first institution studying the effects on sperm of men who receive the vaccine, according to the study’s principal investigator, Ranjith Ramasamy, M.D., associate professor and director of reproductive urology.
UHealth – the University of Miami Health System, the University of Miami Leonard M. Miller School of Medicine, and 4DMedical recently announced the creation of the Functional Lung Imaging Research Program in the Department of Medicine’s Division of Pulmonary, Critical Care and Sleep Medicine at the Miller School.
In a paper published in the journalOcular Immunology and Inflammation, physicians from the Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine reported that several patients using germicidal lamps in an attempt to sanitize against the coronavirus, developed painful inflammation of the cornea, a condition called photokeratitis.
University of Miami Miller School of Medicine and Emory researchers found significant differences in death rates even within the same state, according to a recently published study in Gastroenterology.
Maria T. Abreu, M.D., a renowned gastroenterologist at the University of Miami Miller School of Medicine, was honored with the “Lifetime Disruptor” award at the American College of Gastroenterology’s 2020 virtual meeting.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right